Langerhans cell histiocytosis associated with chronic myelomonocytic leukaemia both harbouring the same BRAF V600E mutation: efficacy of vemurafenib

被引:7
|
作者
Konstantinou, M. P. [1 ]
Lucas, P. [1 ]
Uthurriague, C. [1 ]
Severino-Freire, M. [1 ]
Spenatto, N. [2 ]
Gaudin, C. [3 ]
Lamant, L. [4 ,5 ]
Tournier, E. [4 ,5 ]
Bulai-Livideanu, C. [1 ]
Meyer, N. [6 ,7 ]
Paul, C. [1 ]
机构
[1] Paul Sabatier Univ, Univ Hosp Toulouse, Dermatol Dept, Toulouse, France
[2] Univ Hosp Toulouse, Dermatol Dept & Social Med, Ctr Sexually Transmitted Dis, Toulouse, France
[3] Univ Hosp Toulouse, Geriatr Dept, Toulouse, France
[4] Univ Inst Canc Toulouse Oncopole, Pathol Dept, Toulouse, France
[5] Univ Hosp Toulouse, Toulouse, France
[6] IUC, Dermatol Dept, Toulouse, France
[7] CHU Toulouse, Toulouse, France
关键词
D O I
10.1111/jdv.16850
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E120 / E121
页数:2
相关论文
共 50 条
  • [21] Molecular analysis of BRAF V600E mutation in multiple nodules of pulmonary Langerhans cell histiocytosis
    Arno Dimmler
    Helene Geddert
    Martin Werner
    Gerhard Faller
    Virchows Archiv, 2017, 470 : 429 - 435
  • [22] Vemurafenib in Melanoma with BRAF V600E Mutation REPLY
    Chapman, Paul B.
    Hauschild, Axel
    McArthur, Grant A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1450 - 1450
  • [23] Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia
    Langabeer, Stephen E.
    Quinn, Fiona
    O'Brien, David
    McElligott, Anthony M.
    Kelly, Johanna
    Browne, Paul V.
    Vandenberghe, Elisabeth
    LEUKEMIA RESEARCH, 2012, 36 (04) : 483 - 484
  • [24] Ocular infiltration as initial presentation of acute monocytic leukaemia transformed from chronic myelomonocytic leukaemia associated with BRAF V600E mutation
    Tedjaseputra, Aditya
    Vilcassim, Fathima Shahla
    Grigoriadis, George
    BMJ CASE REPORTS, 2019, 12 (03)
  • [25] BRAF V600E mutation in childhood Langerhans cell histiocytosis correlates with multisystem disease and poor survival
    Bhatia, Prateek
    Singh, Minu
    Sharma, Madhulika
    Sharma, Ajay
    Kakkar, Nandita
    Radhika, S.
    Trehan, Amita
    Bansal, Deepak
    BLOOD CELLS MOLECULES AND DISEASES, 2020, 82
  • [26] BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis
    Ozer, Erdener
    Sevinc, Akin
    Ince, Dilek
    Yuzuguldu, Resmiye
    Olgun, Nur
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2019, 22 (05) : 449 - 455
  • [27] Frequent BRAF(V600E) mutation has no effect on tumor invasiveness in patients with Langerhans cell histiocytosis
    Wei, Rui
    Wang, Zhongqing
    Li, Xiaolin
    Shu, Yigang
    Fu, Bin
    BIOMEDICAL REPORTS, 2013, 1 (03) : 365 - 368
  • [28] Langerhans cell histiocytosis of bone with BRAF V600E mutation: a case report and the review of published work
    Terzi, N. Kaya
    Yilmaz, I.
    VIRCHOWS ARCHIV, 2019, 475 : S414 - S414
  • [29] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    Chapman, Paul B.
    Hauschild, Axel
    Robert, Caroline
    Haanen, John B.
    Ascierto, Paolo
    Larkin, James
    Dummer, Reinhard
    Garbe, Claus
    Testori, Alessandro
    Maio, Michele
    Hogg, David
    Lorigan, Paul
    Lebbe, Celeste
    Jouary, Thomas
    Schadendorf, Dirk
    Ribas, Antoni
    O'Day, Steven J.
    Sosman, Jeffrey A.
    Kirkwood, John M.
    Eggermont, Alexander M. M.
    Dreno, Brigitte
    Nolop, Keith
    Li, Jiang
    Nelson, Betty
    Hou, Jeannie
    Lee, Richard J.
    Flaherty, Keith T.
    McArthur, Grant A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26): : 2507 - 2516
  • [30] Vemurafenib induces senescence in melanoma cells harbouring the V600E mutation
    Haferkamp, S.
    Borst, A.
    Motschenbacher, S.
    Roesch, M.
    Becker, T.
    Adam, C.
    Mayer, L.
    Windhoevel, S.
    Hufnagel, A.
    Houben, R.
    Meierjohann, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 154 - 154